|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Amortization of deferred compensation | |||||
| Stock-based compensation expense | |||||
| Depreciation and amortization expense | |||||
| Amortization of discount on convertible notes | |||||
| Changes in fair value of derivative liabilities | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaids and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Purchase of equipment | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Repurchase of common stock | |||||
| Proceeds from stock option exercise | |||||
| Proceeds from stock warrant exercise | |||||
| Payment for taxes related to net share settlement of stock options and restricted stock units | |||||
| Net cash provided by financing activities | |||||
| Cash, beginning of period | |||||
| Cash, end of period | |||||
| Net change in cash and cash equivalents, and certificate of deposit | |||||
| Cash and cash equivalents, and certificate of deposit, beginning of period | |||||
| Cash and cash equivalents, and certificate of deposit, end of period | |||||
| Supplemental non-cash disclosures: | |||||
| Conversion of convertible notes to stockholders’ equity | |||||
| Conversion of derivative liabilities to stockholders’ equity | |||||
Loading...